Ney Carter Borges։ Clinical Importance of Coronary Microcirculation in MINOCA and INOCA
Ney Carter Borges, Member Cardiologist of Global Physician Association at Cleveland Clinic Florida, shared a post on LinkedIn:
”Clinical Importance of Coronary Microcirculation in MINOCA and INOCA
Coronary microvascular dysfunction (CMD) plays a central and increasingly recognized role in the pathophysiology of angina with non-obstructive coronary arteries, including both myocardial infarction with non-obstructive coronary arteries (MINOCA) and ischemia with non-obstructive coronary arteries (INOCA). Although epicardial coronary arteries may appear angiographically normal or minimally diseased, impairment of the coronary microcirculation leads to inadequate myocardial perfusion, ischemia, and adverse clinical outcomes.
Epidemiological data indicate that INOCA affects up to 40–50% of patients undergoing coronary angiography for angina, with a higher prevalence in women, particularly post-menopausal. In MINOCA, which accounts for approximately 5–10% of all myocardial infarctions, coronary microvascular dysfunction, microvascular spasm, and microembolization are implicated in up to 50–60% of cases when systematically investigated with invasive or advanced imaging techniques.
From a prognostic perspective, CMD is far from benign. Patients with INOCA and documented microvascular dysfunction have a 2–4-fold increased risk of major adverse cardiovascular events (MACE), including cardiovascular death, heart failure hospitalization, and recurrent angina. Reduced coronary flow reserve (CFR <2.0) has been independently associated with a 3-fold increase in cardiovascular mortality over long-term follow-up. Similarly, MINOCA patients demonstrate annual MACE rates of 3–5%, comparable to those observed in patients with obstructive coronary artery disease.
Recognition of coronary microcirculatory pathology in MINOCA and INOCA is therefore critical, not only for accurate diagnosis but also for risk stratification and targeted therapy, shifting clinical focus beyond the epicardial arteries toward the microvascular substrate of ischemic heart disease.
1. Taqueti VR, Di Carli MF.
Coronary microvascular disease: mechanisms and clinical implications.
J Am Coll Cardiol. 2018.
2. Ong P, Camici PG, et al.
Coronary microvascular dysfunction and microvascular angina.
Eur Heart J. 2018.
3. Tamis-Holland JE, et al.
MINOCA: contemporary diagnosis and management.
Circulation. 2019.
4. Pasupathy S, et al.
Myocardial infarction with nonobstructive coronary arteries.
Circulation. 2015.
5. Knuuti J, et al.
ESC Guidelines on chronic coronary syndromes.
Eur Heart J. 2020.”
Stay updated with Hemostasis Today.
-
Apr 3, 2026, 17:59A Free Hemoglobin Screening Camp for Kaikadi Vasti and Eramushti Community Women – Hope Foundation Sironcha
-
Apr 3, 2026, 17:53Carlos Henrique Del Carlo: HFpEF and Iron Deficiency – Why Treating the Mitochondrial Engine Matters More Than We Thought?
-
Apr 3, 2026, 17:46Michelle Leona Cecil: A Call to Protect Patient Care and The Nation’s Blood Supply for Blood Disorders Community
-
Apr 3, 2026, 17:38Shahab Sheikhalishahi: A Rare Case of Portal Vein Thrombosis After Echis Carinatus Envenomation
-
Apr 3, 2026, 17:33Kimberly Ha: Epia Neuro Aims to Restore Movement in Stroke Survivors
-
Apr 3, 2026, 17:28Ryan Perry: Heart and Stroke Announces 2026 Grants-in-Aid Indigenous Research Stream Funding Opportunity
-
Apr 3, 2026, 17:21Maxime Dely: A Meaningful Journey of 14 years in Blood Transfusion
-
Apr 3, 2026, 17:19Arun V J: Don’t Miss TRANSCON 2026 – A Direct Pathway Into India’s Clinical and Institutional Network
-
Apr 3, 2026, 17:17Louise St. Germain Bannon: Preparating for ISTH 2026 and Highlighting Best Aspects of Congress